_20241029113128_original_image_18.webp)
Dozee has unveiled a study demonstrating the effectiveness of its AI-powered Early Warning System (EWS), which can predict patient deterioration up to 16 hours ahead of time.
Read More_20241027214100_original_image_47.webp)
At the 9th edition of CAHOTECH 2024, Dr. Vijay Agarwal, President of the Consortium of Accredited Healthcare Organizations (CAHO), announced several key initiatives aimed at advancing health technology and infection control practices in India.
Read More_20241026234427_original_image_20.webp)
At the 9th edition of CAHOTECH 2024, Dr Vijay Agarwal, President of the Consortium of Accredited Healthcare Organisations (CAHO), made two key announcements.
Read More_20241026134003_original_image_49.webp)
At the 9th edition of CAHOTECH 2024, Karnataka's Minister for Health & Family Welfare, Dinesh Gundu Rao, delivered a forward-looking address, emphasising the potential of technology in healthcare.
Read More (1)_20241026114433_original_image_43.webp)
At the 9th edition of CAHOTECH, Dr. Devi Shetty, founder of Narayana Health, shared insights into the two-decade journey of building their digital healthcare platform, Athma.
Read More_20241026105321_original_image_48.webp)
The 9th edition of CAHOTECH, at the J.N. Tata Auditorium in Bangalore, brought together leaders and innovators from healthcare and technology sectors. The theme, "Redefining Healthcare: Technology as the Catalyst for Change," sets the stage for a day of insightful discussions aimed at accelerating innovation in healthcare.
Read More_20241025114052_original_image_2.webp)
The CAHO Masterclass for Startups, taking place on 25 October 2024 at the J.N. Tata Auditorium, will provide a comprehensive roadmap for healthcare entrepreneurs looking to bring their innovations to market.
Read More_20241025111505_original_image_9.webp)
The CAHOTECH 2024 Pitch Fest, happening today, promises to be an exciting platform for healthcare startups and innovators to present their groundbreaking solutions.
Read More
Corneal blindness is rising sharply in India, with an estimated 20,000 to 25,000 new cases annually. This adds to the existing 12 lakh cases, making corneal blindness one of the major contributors to vision loss, accounting for 7.5 per cent of the total blindness burden in the country.
Read More
The UK’s Medicines and Healthcare products Regulatory Agency has approved Eli Lilly's new treatment for early-stage Alzheimer’s disease, donanemab, marketed under the brand name Kisunla.
Read More
